Published in J Nerv Ment Dis on December 21, 2016
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry (1994) 48.75
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA (2000) 9.58
Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA (1995) 4.40
Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry (1999) 4.31
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry (2005) 3.46
Improving care for minorities: can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. Health Serv Res (2003) 3.13
Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA (2001) 3.08
Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand (2006) 2.99
Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res (2009) 2.98
The role of competing demands in the treatment provided primary care patients with major depression. Arch Fam Med (2000) 2.75
Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. Arch Gen Psychiatry (2004) 2.51
Does stigma keep poor young immigrant and U.S.-born Black and Latina women from seeking mental health care? Psychiatr Serv (2007) 2.05
The design of Partners in Care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol (1999) 1.88
Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry (2001) 1.62
Social functioning in depression: a review. J Clin Psychiatry (2000) 1.62
Cost-effectiveness of quality improvement programs for patients with subthreshold depression or depressive disorder. Psychiatr Serv (2007) 1.61
Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry (1999) 1.52
Effects of primary care depression treatment on minority patients' clinical status and employment. Arch Gen Psychiatry (2004) 1.32
Two-year effects of quality improvement programs on medication management for depression. Arch Gen Psychiatry (2001) 1.23
The effects of quality improvement for depression in primary care at nine years: results from a randomized, controlled group-level trial. Health Serv Res (2008) 1.08
Impact of a primary care quality improvement intervention on use of psychotherapy for depression. Ment Health Serv Res (2003) 1.06
The Partnered Research Center for Quality Care: developing infrastructure to support community-partnered participatory research in mental health. Ethn Dis (2011) 1.02
The cumulative effects of quality improvement for depression on outcome disparities over 9 years: results from a randomized, controlled group-level trial. Med Care (2007) 0.97
Stigma of depression--a personal view. Br Med Bull (2001) 0.85
Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial. J Affect Disord (2005) 0.82
Cost-effectiveness of interventions for depressed Latinos. J Ment Health Policy Econ (2004) 0.80
Quality of care for depressed elderly pre-post prospective payment system: differences in response across treatment settings. Med Care (1994) 0.77
The Fracture of Relational Space in Depression: Predicaments in Primary Care Help Seeking. Curr Anthropol (2016) 0.75
Strategies for academic and clinician engagement in community-participatory partnered research. JAMA (2007) 9.11
Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv (2008) 5.00
Witness for Wellness: preliminary findings from a community-academic participatory research mental health initiative. Ethn Dis (2006) 2.38
Collaborative depression care: history, evolution and ways to enhance dissemination and sustainability. Gen Hosp Psychiatry (2010) 1.84
Generalizability of studies on mental health treatment and outcomes, 1981 to 1996. Psychiatr Serv (2005) 1.74
Baseline dimensions of the human vagina. Hum Reprod (2006) 1.59
The vision, valley, and victory of community engagement. Ethn Dis (2009) 1.45
The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation. Genome Biol (2008) 1.35
Effects of primary care depression treatment on minority patients' clinical status and employment. Arch Gen Psychiatry (2004) 1.32
Ethical community-engaged research: a literature review. Am J Public Health (2013) 1.30
Using a community partnered participatory research approach to implement a randomized controlled trial: planning community partners in care. J Health Care Poor Underserved (2010) 1.29
Obstacles and opportunities in providing mental health services through a faith-based network in Los Angeles. Psychiatr Serv (2005) 1.26
An Exploration of the Effect of Community Engagement in Research on Perceived Outcomes of Partnered Mental Health Services Projects(). Soc Ment Health (2011) 1.25
On measuring community participation in research. Health Educ Behav (2012) 1.22
Determining the protein repertoire of Cryptosporidium parvum sporozoites. Proteomics (2008) 1.21
Promoting mental health recovery after hurricanes Katrina and Rita: what can be done at what cost. Arch Gen Psychiatry (2009) 1.20
Proteomic comparison of four Eimeria tenella life-cycle stages: unsporulated oocyst, sporulated oocyst, sporozoite and second-generation merozoite. Proteomics (2009) 1.12
Characterisation of Plasmodium invasive organelles; an ookinete microneme proteome. Proteomics (2009) 1.07
Begin your partnership: the process of engagement. Ethn Dis (2009) 1.07
Impact of a primary care quality improvement intervention on use of psychotherapy for depression. Ment Health Serv Res (2003) 1.06
Applying community engagement to disaster planning: developing the vision and design for the Los Angeles County Community Disaster Resilience initiative. Am J Public Health (2013) 1.06
Innovative approaches to obtaining community feedback in the Witness for Wellness experience. Ethn Dis (2006) 1.04
Screening for domestic violence among adult women in the United States. J Gen Intern Med (2007) 1.04
Community Partners in Care: Leveraging Community Diversity to Improve Depression Care for Underserved Populations. Int J Divers Organ Communities Nations (2009) 1.02
Talaporfin sodium. Expert Opin Pharmacother (2010) 0.95
Applying health care reform principles to mental health and substance abuse services. JAMA (2009) 0.93
12-month outcomes of community engagement versus technical assistance to implement depression collaborative care: a partnered, cluster, randomized, comparative effectiveness trial. Ann Intern Med (2014) 0.92
Plasmodium male development gene-1 (mdv-1) is important for female sexual development and identifies a polarised plasma membrane during zygote development. Int J Parasitol (2008) 0.91
Community perspectives: mixed-methods investigation of culture, stress, resilience, and health. Ethn Dis (2010) 0.90
From subject to participant: ethics and the evolving role of community in health research. Am J Public Health (2015) 0.87
Expression of functionally active cannabinoid receptor CB1 in the human prostate gland. Prostate (2003) 0.87
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. Dis Model Mech (2012) 0.86
Partnered evaluation of a community engagement intervention: use of a kickoff conference in a randomized trial for depression care improvement in underserved communities. Ethn Dis (2011) 0.86
Work through the valley: do. Ethn Dis (2009) 0.84
The rhoptry proteome of Eimeria tenella sporozoites. Int J Parasitol (2012) 0.83
Factors affecting exits from homelessness among persons with serious mental illness and substance use disorders. J Clin Psychiatry (2015) 0.82
Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat. J Am Soc Nephrol (2005) 0.82
Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trial. J Affect Disord (2005) 0.82
Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Med Genomics (2011) 0.81
Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy. Nephrol Dial Transplant (2010) 0.80
Celebrate victory. Ethn Dis (2009) 0.80
Cost-effectiveness of interventions for depressed Latinos. J Ment Health Policy Econ (2004) 0.80
Relationship of community integration of persons with severe mental illness and mental health service intensity. Psychiatr Serv (2014) 0.79
How quality improvement interventions for depression affect stigma concerns over time: a nine-year follow-up study. Psychiatr Serv (2009) 0.79
Clinical and subthreshold panic disorder. Depress Anxiety (2010) 0.79
Perceived sources of stress and resilience in men in an African American community. Prog Community Health Partnersh (2014) 0.77
Develop a vision. Ethn Dis (2009) 0.77
A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury. J Biomed Biotechnol (2010) 0.77
Community engagement in disaster preparedness and recovery: a tale of two cities--Los Angeles and New Orleans. Psychiatr Clin North Am (2013) 0.77
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists. Bioorg Med Chem Lett (2010) 0.76
Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists. Bioorg Med Chem Lett (2010) 0.76
Social Support and Housing Transitions Among Homeless Adults With Serious Mental Illness and Substance Use Disorders. Psychiatr Rehabil J (2016) 0.75
Project overview of the Restoration Center Los Angeles: steps to wholeness--mind, body, and spirit. Ethn Dis (2011) 0.75
Novel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathy. J Diabetes Res (2013) 0.75
Older depressed Latinos' experiences with primary care visits for personal, emotional and/or mental health problems: a qualitative analysis. Ethn Dis (2014) 0.75
A Community Engagement Symposium to Prevent and Improve Stroke Outcomes in Diverse Communities. Prog Community Health Partnersh (2016) 0.75
Community-Partnered Development of a Digital Mental Health Resource Website to Support Diverse Communities During the COVID-19 Pandemic. J Health Care Poor Underserved (2022) 0.75
Parathyroid hormone-related protein is a hypertrophy factor for human mesangial cells: Implications for diabetic nephropathy. J Cell Physiol (2012) 0.75
Entraining synthetic genetic oscillators. Chaos (2009) 0.75
Patient centered, nurse averse? Nurses' care experiences in a 21st-century hospital. Qual Health Res (2012) 0.75
Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care. Am J Drug Alcohol Abuse (2007) 0.75
A community partnered-participatory research approach to reduce cancer disparities in South Los Angeles. Prog Community Health Partnersh (2014) 0.75
How does the persistence of depression influence the continuity and type of health insurance and coverage limits on mental health therapy? J Ment Health Policy Econ (2007) 0.75